After a rocky year, Adobe has added artificial intelligence tools to its stock photography library. So what about the ...

Shares of AbbVie plummeted Monday after the company said its schizophrenia drug Emraclidine missed key goals in a pair of trials.

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Emraclidine was expected to be a blockbuster drug for AbbVie, and this development didn’t sit well with investors.

Asian stocks fell, following a record-setting day for U.S. stocks, as China’s stimulus package disappointed investor ...

Ulrich Renz, a former head of The Associated Press German-language service who also covered trials of leaders of the ...

The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...

77% of Tesla's stock value—$816 Billion—is realized thanks to its forward ... That is, of course, assuming that Tesla ...

Emu and First Responder won’t replace the current CT or MRI-based stroke imaging methods, but create high-contrast, supplementary images. Emvision is vying for US Food & Drug Administration (FDA ...

Satellite images and public documents helped identify likely carrier ... All three carriers are conventionally powered. Sea ...